BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Khorana AA, DeSancho MT, Liebman H, Rosovsky R, Connors JM, Zwicker J. Prediction and Prevention of Cancer-Associated Thromboembolism. Oncologist 2021;26:e2-7. [PMID: 33274815 DOI: 10.1002/onco.13569] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Khorana AA, Mackman N, Falanga A, Pabinger I, Noble S, Ageno W, Moik F, Lee AYY. Cancer-associated venous thromboembolism. Nat Rev Dis Primers 2022;8:11. [PMID: 35177631 DOI: 10.1038/s41572-022-00336-y] [Reference Citation Analysis]
2 Makó K. Current Recommendations for the Management of Cancer-Associated Venous Thromboembolism. Journal Of Cardiovascular Emergencies 2021;7:27-38. [DOI: 10.2478/jce-2021-0009] [Reference Citation Analysis]
3 Abdel-Razeq H, Ma'koseh M, Mansour A, Bater R, Amarin R, Abufara A, Halahleh K, Manassra M, Alrwashdeh M, Almomani M, Zmaily M. The Application of the ThroLy Risk Assessment Model to Predict Venous Thromboembolism in Patients with Diffuse Large B-Cell Lymphoma. Clin Appl Thromb Hemost 2021;27:10760296211045908. [PMID: 34590497 DOI: 10.1177/10760296211045908] [Reference Citation Analysis]
4 West MT, Kartika T, Paquin AR, Liederbauer E, Zheng TJ, Lane L, Thein K, Shatzel JJ. Thrombotic events in patients using cyclin dependent kinase 4/6 inhibitors, analysis of existing ambulatory risk assessment models and the potential influences of tumor specific risk factors. Curr Probl Cancer 2022;:100832. [PMID: 35034766 DOI: 10.1016/j.currproblcancer.2021.100832] [Reference Citation Analysis]